STAR Protocols (Jun 2022)

Generation and application of TGFβ-educated human Vγ9Vδ2 T cells

  • Ana C. Parente-Pereira,
  • Richard E. Beatson,
  • David M. Davies,
  • Caroline Hull,
  • Lynsey M. Whilding,
  • Joanna C. Porter,
  • John Maher

Journal volume & issue
Vol. 3, no. 2
p. 101319

Abstract

Read online

Summary: Clinical trials that tested the antitumor activity of γδ T cells have been mostly unsuccessful. To address this, we expanded human Vγ9Vδ2 T cells in TGFβ1, a cytokine which enhances their viability, trafficking properties, and intrinsic antitumor activity. This protocol summarizes the production and in vitro functional characterization of TGFβ1 educated human Vγ9Vδ2 cells and highlights their compatibility with chimeric antigen receptor (CAR) engineering. We also describe in vivo testing of the antitumor activity of these CAR T cells in mice.For complete details on the use and execution of this protocol, please refer to Beatson et al. (2021).

Keywords